Novo Nordisk said on Wednesday it plan to file its experimental next-generation obesity drug CagriSema for regulatory ...
SolarWinds is set to be acquired by Turn/River Capital for $4.4 billion. Shareholders will get $18.50 per share.
Trump embraced digital assets during his campaign, promising to make the U.S. the "crypto capital of the planet" and to ...
Asset management behemoth, Franklin Templeton Investments (NYSE:BEN), is seeking regulatory approval to launch a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback